ALISKIREN AND VALSARTAN LIMIT MYOCARDIAL INFARCT SIZE IN DIABETIC MICE

被引：0
|
作者：
Ye, Yumei
Qian, Jianqiao
Perez-Polo, Jose R.
Birnbaum, Yochai
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 14期
关键词：
D O I：
10.1016/S0735-1097(11)61012-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1012 / E1012
页数：1
相关论文
共 50 条
  • [1] Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice
    Yumei Ye
    Jinqiao Qian
    Alexander C. Castillo
    Jose Regino Perez-Polo
    Yochai Birnbaum
    [J]. Cardiovascular Drugs and Therapy, 2011, 25 : 505 - 515
  • [2] Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice
    Ye, Yumei
    Qian, Jinqiao
    Castillo, Alexander C.
    Perez-Polo, Jose Regino
    Birnbaum, Yochai
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (06) : 505 - 515
  • [3] Protective effects of aliskiren and valsartan in mice with diabetic nephropathy
    Wang, Weidong
    Qiu, Liru
    Howard, Allison
    Solis, Nathaniel
    Li, Chunling
    Wang, Xiaoxin
    Kopp, Jeffrey B.
    Levi, Moshe
    [J]. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2014, 15 (04) : 384 - 395
  • [4] Haptoglobin genotype determines myocardial infarct size in diabetic mice
    Blum, Shany
    Asaf, Roy
    Guetta, Julia
    Miller-Lotan, Rachel
    Asleh, Rabea
    Kremer, Ran
    Levy, Nina S.
    Berger, Franklin G.
    Aronson, Doron
    Fu, Xiaoming
    Zhang, Renliang
    Hazen, Stanley L.
    Levy, Andrew P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (01) : 82 - 87
  • [5] Haptoglobin genotype determines myocardial infarct size in diabetic mice
    Blum, Shany
    Asaf, Roy
    Guetta, Julia
    Miller-Lotan, Rachel
    Asleh, Rabea
    Kremer, Ran
    Levy, Nina S.
    Aronson, Donon
    Fu, Xiaoming
    Zhang, Renliang
    Hazen, Stanley L.
    Levy, Andrew P.
    [J]. CIRCULATION, 2006, 114 (18) : 97 - 97
  • [6] Haptoglobin genotype determines myocardial infarct size in diabetic mice
    Blum, S
    Guetta, J
    Miller-Lotan, R
    Asleh, R
    Asaf, R
    Kremer, R
    Berger, FG
    Levy, NS
    Levy, AP
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 381A - 381A
  • [7] Aliskiren Decreases Myocardial AT-1, Increases SIRT1 and PGC-1α, and Limits Infarct Size in Diabetic Mice
    Birnbaum, Yochai
    Qian, Jianqiao
    Perez-Polo, Jose R.
    Ye, Yumei
    [J]. HYPERTENSION, 2011, 58 (05) : E74 - E74
  • [8] CALCIUM-ANTAGONISTS LIMIT MYOCARDIAL INFARCT SIZE
    YELLON, DM
    DOWNEY, JM
    HEARSE, DJ
    MAXWELL, MP
    YOSHIDA, S
    [J]. CIRCULATION, 1983, 68 (04) : 186 - 186
  • [9] EFFORTS TO LIMIT MYOCARDIAL INFARCT SIZE - HISTORICAL CONSIDERATIONS
    BRAUNWALD, E
    [J]. EUROPEAN HEART JOURNAL, 1985, 6 : 1 - 4
  • [10] Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice
    Dong, Yi-Fei
    Liu, Lei
    Lai, Zhong-Fang
    Yamamoto, Eiichiro
    Kataoka, Keiichiro
    Nakamura, Taishi
    Fukuda, Masaya
    Tokutomi, Yoshiko
    Nako, Hisato
    Ogawa, Hisao
    Kim-Mitsuyama, Shokei
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 (07) : 1554 - 1565
12345